脂肪酸氧化障碍患者的营养管理
Luis Peña-Quintana1,2, Patricia Correcher-Medina2,3
1Pediatric Gastroenterology and Nutrition Unit, Insular Materno-Infantil University Hospital Complex, Asociación Canaria de Investigación Pediátrica, Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición ISCIII, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
Nutrients
|August 29, 2024
概括
管理脂肪酸氧化障碍涉及饮食变化,药物治疗和预防代谢危机. 关键策略包括确保足够的葡萄糖摄入量,避免禁食,根据特定疾病量身定制脂肪和碳水化合物摄入量. 新的治疗方法正在出现.
科学领域:
- 生物化学 生物化学
- 代谢障碍 代谢障碍 代谢障碍
- 营养科学 营养科学
背景情况:
- 脂肪酸氧化障碍 (FAOD) 是一组遗传代谢疾病,这些疾病损害了身体分解脂肪以获得能量的能力.
- 这些疾病可能导致严重的健康问题,包括肌肉衰弱,心脏问题,肝损伤和发育迟缓.
- 有效的管理对于预防可能危及生命的代谢失补偿至关重要.
研究的目的:
- 为各种脂肪酸氧化障碍概述当前的饮食,药理和代谢管理策略.
- 突出葡萄糖供应和脂肪限制在预防脂解中的重要性.
- 讨论长链,中链和短链缺陷的具体营养建议,包括补充和紧急治疗方案.
主要方法:
- 饮食管理侧重于预防禁食和调整脂肪和碳水化合物摄入量.
- 关于长链甘油三酸 (LCT) 和中链甘油三酸 (MCT) 摄入的具体建议.
- 药理方面的考虑,包括使用三他因和有争议的卡尼丁的作用.
- 管理急性代谢失补偿和运动相关风险的指导方针.
主要成果:
- 足够的葡萄糖摄入量对于防止脂解和利用脂肪酸至关重要.
- 饮食管理因FAOD类型而异,对于长链缺陷,LCT限制和MCT补充有益.
- 三他因作为一种治疗选择显示出前途.
- 运动前的MCT或碳水化合物可以预防风险患者的狂犬病溶解.
- 静脉注射葡萄糖是主要的紧急治疗方法;卡尼丁的作用仍在争论中.
结论:
- 对FAOD的全面管理需要涉及饮食,药物和应急准备的多方面的方法.
- 个性化的饮食策略,特别是碳水化合物负载和脂肪修饰,是预防代谢危机的关键.
- 对新型治疗方案的持续研究对于改善患者的治疗结果至关重要.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
77
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
77
01:28Overview of Fatty Acid Metabolism
30.3K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.3K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
01:24Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K
01:24Cystic Fibrosis: Management
146
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
146
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K